Moving the boundaries of international collaboration on clinical trials and QoL: experiences in oncology and legislation within the European Parliament

Author： Bottomley Andrew   Kirby Tony   Bean John   Walker Julie  

Publisher： Informa Healthcare

ISSN： 1473-7167

Source： Expert Review of Pharmacoeconomics and Outcomes Research, Vol.13, Iss.1, 2013-02, pp. : 43-45

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ensuring the quality of QOL instruments for use in clinical trials

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 462, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Rifaximin improves QoL in hepatic encephalopathy

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 603, 2010-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

New legislation puts clinical trials in US "public arena"

By  

Reactions Weekly, Vol. 1, Iss. 1176, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

New US legislation puts clinical trials in "public arena"

By  

Inpharma, Vol. 1, Iss. 1612, 2007-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Missing Data and Censoring in the Analysis of Progression-Free Survival in Oncology Clinical Trials

By Denne J. S.   Stone A. M.   Bailey-Iacona R.   Chen T.-T.  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 5, 2013-09 ,pp. : 951-970

Taylor & Francis Ltd

Access to resources Recommend Favorite